The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.

Wilczek, H E; Berglin, E; Blohmé, I; Bäckman, L; Fehrman, I; Källen, R; Nyberg, G; Säwe, J; Wahlberg, J

Wilczek, H E; Berglin, E; Blohmé, I; Bäckman, L; Fehrman, I; Källen, R; Nyberg, G; Säwe, J; Wahlberg, J.

Affiliation

Wilczek HE; Dept of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.

Transplant Proc ; 29(1-2): 280-3, 1997.

Article in En | MEDLINE | ID: mdl-9122995

Subject(s)

Cyclosporine/therapeutic use; Immunosuppressive Agents/therapeutic use; Administration, Oral; Cyclosporine/administration & dosage; Cyclosporine/pharmacokinetics; Dosage Forms; Heart Transplantation/immunology; Heart-Lung Transplantation/immunology; Humans; Immunosuppressive Agents/administration & dosage; Immunosuppressive Agents/pharmacokinetics; Kidney Transplantation/immunology; Liver Transplantation/immunology; Pancreas Transplantation/immunology; Sweden

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cyclosporine / Immunosuppressive Agents Type of study: Clinical_trials Limits: Humans Country/Region as subject: Europa Language: En Journal: Transplant Proc Year: 1997 Document type: Article Affiliation country: Sweden

Search on Google

Add to My VHL

XML

PubMed Links